Placebo TDS

DRUG3 trials

Sponsors

Vice Chancellor for Research, School of Medicine, Isfahan University of Medical Sciences, Senju USA, Inc.

Conditions

ChalazionPruritus in peritoneal Patients. End-stage renal disease

Phase 2

Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

CompletedNCT02338648

Senju USA, Inc.Chalazion

Start: 2014-10-31End: 2016-01-31Updated: 2017-08-11

Phase 3

Evaluation of the effect of omega3 on pruritus in patients under peritoneal dialysis

Active, not recruitingIRCT138808202370N5

Vice Chancellor for Research, School of Medicine, Isfahan University of Medical SciencesPruritus in peritoneal Patients. End-stage renal disease

Start: 2009-08-20Target: 60Updated: 2018-02-22

Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion

CompletedNCT03248440

Senju USA, Inc.Chalazion

Start: 2017-07-31End: 2018-08-17Updated: 2021-08-05